Events

Upcoming Events

Upcoming events

Call for ideas:

Driving innovation in personalized medicine through translational research and collaboration

Whether you have developed an idea, have an invention to protect, whether you are planning a technological maturation or business creation project, this opportunity is for you!

CQDM and Axelys are delighted to announce a unique opportunity for all Quebec researchers and companies to contribute to the rapidly evolving field of personalized medicine. In this context, CQDM and Axelys are opening a call for ideas that explore technological approaches or solutions in personalized medicine, developed within your organizations.

The complexity and variability of human biology make personalized medicine an essential approach to health. In particular, it provides targeted, effective and patient-centered prevention, diagnosis and treatment tools. By leveraging technologies such as genomics, proteomics, metabolomics, digital health technologies, personalized medicine offers the potential for increased prediction and prevention, as well as precise and more effective therapeutic strategies.

In order to realize the potential of these scientific innovations, it is crucial to foster strong interdisciplinary partnerships to understand and respond to market requirements, access cutting-edge expertise to bridge the “valley of death” between research and clinical application.

For this reason, we invite all members of the ecosystem involved in this theme, including researchers from Quebec universities and established companies of all sizes, to submit ideas that:

  • Improve or apply technology developed within an academic institution or in an industrial environment.
  • Explore innovative approaches to improve prevention, diagnosis, treatment and personalized patient care by improving the overall patient experience, while ensuring that complexity and associated costs are reduced.
  • Continue the development of cutting-edge technologies, with a critical eye on their harmonious integration into the existing health ecosystem, with a view to commercialization that respects the principles of sustainability, accessibility, and continuous improvement of care.
  • Whether or not they include collaboration between industry and academic centres.

We encourage proposals that demonstrate a real understanding of the current and future challenges of the health system, with an emphasis on inclusive and responsible innovation that benefits all users of the health system, without increasing its complexity.

The deadline for submitting ideas is March 15, 2024 at the latest.

The ideas submitted will be evaluated by the Axelys and CQDM teams who will ensure feedback to the depositors in a concerted manner. Depending on the nature of the ideas submitted, the most relevant support, accompaniement and financing opportunities for the development of the technologies will be offered. With the agreement of the depositors, the ideas can also be discussed with other partner organizations in order to respond most appropriately to the stated needs.

This initiative led by CQDM and Axelys concretizes our joint effort to bring out promising technologies in personalized medicine in order to integrate them into clinical practice. Through the efforts and active participation of all, we have the potential to revolutionize healthcare delivery by enabling the development of targeted treatments that minimize adverse effects, improve clinical outcomes and enhance patient well-being.

Join us in shaping the future of care by sending us your innovative proposals, which will undoubtedly lead to improved prevention, diagnosis, therapy and monitoring of diseases, particularly chronic, complex and rare diseases.

Below you will find the template and instructions for submitting your application. These must be sent no later than March 15, 2024 to the following email address: Apply-apply@cqdm.org. Click here for the template.

For any questions, please contact Mathieu Paquette, CQDM, at:

mpaquette@cqdm.org

Connect-Pharma: Pitch Day

Call for Ideas: Induced proximity- PROTACs and other bifunctional molecules

CQDM is pleased to launch its second call for ideas for our upcoming CQDM Connect-Pharma: Pitch Day.

We are searching for world-class research to develop novel and efficient approaches for proximity-based modalities to present to domain experts from leading global pharmaceutical organizations on February 22, 2024.

Projects that gain pharma interest are eligible to obtain funding via CQDM’s Quantum Leap program.

We invite passionate Canadian researchers and visionary teams to submit innovative ideas that have the potential to transform the landscape of medicine and improve patient outcomes.

Research Focus Areas: We are particularly interested in technologies that explore, but are not limited to, the following research areas:

  • Proteolysis-targeting chimeras (PROTACs)
  • PROTACs as antiviral or anticancer viral origin oncogenesis
  • Antibody-drug conjugates with PROTACs
  • Molecular glues
  • Aptamers
  • Lysosome-targeting chimeras (LYTACs)
  • Deubiquitinase-targeting chimeras (DUBTACs)
  • Linker chemistry
  • Bi/multispecific antibodies
  • Novel E3 ligases and ligands
  • AI/ML/Computational approaches
  • Protein-protein interactions
  • Target RNAs for degradation (RIBOTACs or ribonuclease targeting chimeras)
  • Inclusion of degradation domains for live attenuated vaccines

We are seeking ideas that demonstrate creativity, scientific rigor, and a strong potential for real-world applications.

Process: All submitted projects will be shared with CQDM’s pharmaceutical members for review and ranking. Top ranked projects will be selected to present to CQDM’s global pharmaceutical members at a CQDM Connect-Pharma: Pitch Day on February 22, 2024.

Who can apply: Canadian academic institutions, biotech companies, and research organizations are eligible to apply. Collaborative projects that involve partnerships between academia and industry are also encouraged. We welcome multidisciplinary teams that can bring diverse expertise to the table.

Deadline and Submission: Submission deadline is January 15, 2024, please submit to appliquez-apply@cqdm.org. Detailed guidelines and instructions for proposal submission and selection form are available here, via the application form.

Past events

Exclusive event.

Connect-Pharma: Pitch Day – Call for Ideas: Targeted Delivery of Drugs

We are searching for world-class research to develop novel and efficient approaches for targeted delivery of small molecules, biologics, vaccines, or nucleic acids to present to domain experts from leading global pharmaceutical organizations on October 19, 2023.

Projects that gain pharma interest eligible to obtain funding via CQDM’s Quantum Leap program.

We invite passionate Canadian researchers and visionary teams to submit innovative ideas that have the potential to transform the landscape of medicine and improve patient outcomes.

Research Focus Areas: We are particularly interested in technologies that explore, but are not limited to, the following research areas (any medical indication):

  • Tissue/cell specific delivery platforms
  • Non-viral delivery systems
  • Nanotechnology-based delivery systems
  • Biomaterials for targeted drug/nucleic acid delivery
  • Ligand-targeted therapies for specific diseases
  • Advanced gene editing technologies for precision medicine
  • RNA-based therapeutics and delivery strategies

We are seeking ideas that demonstrate creativity, scientific rigor, and a strong potential for real-world applications.

Process: All submitted projects will be shared with CQDM’s pharmaceutical members for review and ranking. Top ranked projects will be selected to present to CQDM’s global pharmaceutical members at a Connect-Pharma: Pitch Day on October 19, 2023.

Who can apply: Canadian academic institutions, biotech companies, and research organizations are eligible to apply. Collaborative projects that involve partnerships between academia and industry are also encouraged. We welcome multidisciplinary teams that can bring diverse expertise to the table.

Deadline and Submission: Submission deadline is September 20, 2023, please submit to appliquez-apply@cqdm.org. Detailed guidelines and instructions for proposal submission and the selection form are available here, through this application form.

Want more information? Contact:

 

Jesse Paterson, CQDM : jpaterson@cqdm.org

Simon Fournier, CQDM : sfournier@cqdm.org

Webinar of June 20th, 2023

You have missed our June 20th, 2023 webinar? You can see the recording here!

Webinar of May 31th, 2023

Watch our webinar entitled “Cultivating Precision Medicine” which took place on May 31, 2023

CIBC Run for the Cure!

October 2, 2022: CQDM team participated in the Canadian Cancer Society’s CIBC Run for the Cure!

Sweet Biopharma Day‘s 3rd Edition | Québec, Canada Call for startup proposals, now open

We are pleased to announce that the 3rd edition of Sweet Biopharma Day will be held, in person, on April 12, 2023. This unique, by invitation-only event invites young Canadian biotechs to submit an application for a chance to present in front of key global biopharma companies, as well as leading Canadian life sciences ecosystem’s stakeholders (such as venture capitalists and representatives from governments and associations). The intent is to develop potential collaborations or partnerships.

Are you a biotechnology start-up or company with fewer than 25 employees and focused on innovative research and development? Do you have a strong commercial potential? You can apply for the chance to be among the 16 promising Canadian biotech companies, the “Sweet 16”, who will be invited to present in front of key biopharmaceutical industry stakeholders on April 12th.

How to apply: Companies must provide a 2-page executive summary and a short presentation (one set of no more than 5 slides) describing their cutting-edge technology, target indications, and points of differentiation. Application packages must be submitted via this form no later than Wednesday, March 8, 2023, at 11:59 p.m. EDT.

CQDM completed its series of three Webinars: The Evolving Landscape of AI Implementation in New Drug Discovery & Development!

We are extremely grateful to Philip Tagari, VP of Research (Therapeutic Discovery) at Amgen for chairing the Webinars. We also wish to thank all of our speakers and panelists!

Where to watch the webinars?

« Using Machine Learning on Publicly Available Biomedical Data for Target Discover »

« Generation of Innovative Therapeutics using Artificial Intelligence »

« From Candidates to Drugs – Applications of Artificial Intelligence in Translational Research »

Do you have any topic to suggest for the next series?

Write us your ideas at: info@cqdm.org

Scroll to Top